Objectives With the COVID-19 pandemic, repetitive lung examinations have become
necessary to follow-up symptoms and associated alterations. Low-field MRI, benefiting from …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to an
adaptive immune response in the host and the formation of anti-SARS-CoV-2 specific …

Endocannabinoids and endocannabinoid-related compounds (ERCs) are involved in many
physiological processes. They are released on demand from phosphoinositide and N-…

Immune checkpoint inhibitors (ICIs) are effective oncological drugs which block cellular
check-point receptors typically targeted by tumor immune evasion strategies. Despite their …

BACKGROUND Massive hemorrhage usually results in rapid need of blood products.
Patients in need of fresh frozen plasma (FFP) might benefit from shorter thawing times using a …

Abstract Treatment with convalescent plasma has been shown to be safe in coronavirus
disease in 2019 (COVID‐19) infection, although efficacy reported in immunocompetent patients …

SARS-CoV-2 antibody assays are used for epidemiological studies and for the assessment
of vaccine responses in highly vulnerable patients. So far, data on cross-reactivity of SARS-…

Background Allergies are on the rise globally, with an enormous impact on affected individuals’
quality of life as well as health care resources. They cause a wide range of symptoms, …

In the current pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2;
COVID-19), a better understanding of the underlying mechanisms is essential to …

Background Antithrombin (AT) is an important anticoagulant in hemostasis. We describe here
the characterization of a novel AT mutation associated with clinically relevant thrombosis. …